Lu Gan

9k citations
185 papers · 7.6k · 3 hit papers · h-index 49

Impact in

Papers in

    • Nanoparticle-Based Drug Delivery 29
    • Cancer Immunotherapy and Biomarkers 9
    • Cancer Cells and Metastasis 7

Lu Gan

173 papers receiving 7.5k citations

Lu Gan's Hit Papers

Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts 2022 · 226 citations
2260+2+4Years since publication200400600

Peers

Lu Gan
Comparison fields: 5 of 134
  • Biomaterials 1.4k
  • Biomedical Engineering 1.5k
  • Molecular Medicine 230
  • Cancer Research 415
  • Oncology 682
Replace Jie Chen with:
Jie Chen China
Zhaohui Wang China
Yu Zhao China
Hai Wang China
Phei Er Saw China
Jing Li China
Ramasamy Paulmurugan United States
Jianfeng Guo China
Shiladitya Sengupta United States
Yin Wang China
Lu Gan relative to Jie Chen China Jie Chen's profile →
Citations per field
00.5×1.5×1.8×
Jie Chen · 1×
Citations per year

Countries citing papers authored by Lu Gan

Since Specialization
Citations

This map shows the geographic impact of Lu Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Gan more than expected).

Fields of papers citing papers by Lu Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Gan. The network helps show where Lu Gan may publish in the future.

Co-authors

The 25 scholars most cited alongside Lu Gan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lu Gan Line = papers co-authored together Lu Gan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 185 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
Hit paper breakdown →
2019731
2 2018328
3
Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles
Hit paper breakdown →
2021296
4 2020274
5 2010227
6
Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts
Hit paper breakdown →
2022226
7 2019202
8 2020183
9 2001165
10 2011158
11 2021132
12 2016125
13 2017125
14 2015118
15 2018108
16 2022108
17 2021107
18 2015101
19 202098
20 201794

About Lu Gan

Lu Gan is a scholar working on Biomaterials, Oncology, Cancer Research, Molecular Biology and Biomedical Engineering, having authored 185 papers that have together received 7.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (29 papers), Nanoplatforms for cancer theranostics (14 papers), Extracellular vesicles in disease (14 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer Cells and Metastasis (7 papers), Immunotherapy and Immune Responses (7 papers), Perovskite Materials and Applications (7 papers) and Hydrogels: synthesis, properties, applications (5 papers). The work is most often cited by research in Biomaterials (1.4k citations), Biomedical Engineering (1.5k citations), Molecular Medicine (230 citations), Cancer Research (415 citations) and Oncology (682 citations). Lu Gan has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xiangliang Yang, Tuying Yong, Nana Bie, Xiaoqiong Zhang, Zhaohan Wei, Guiting Zhan, Abdul Hakeem, Haiping He, Jun Hu and Zhizhen Ye. Their work appears in journals such as ACS Applied Materials & Interfaces, Theranostics, Advanced Science, Journal of Controlled Release and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact